AU2087897A - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number
AU2087897A
AU2087897A AU20878/97A AU2087897A AU2087897A AU 2087897 A AU2087897 A AU 2087897A AU 20878/97 A AU20878/97 A AU 20878/97A AU 2087897 A AU2087897 A AU 2087897A AU 2087897 A AU2087897 A AU 2087897A
Authority
AU
Australia
Prior art keywords
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU20878/97A
Inventor
Ronald Harding
Kivalur Subramaniasarma Swaminathan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mayne Pharma International Pty Ltd
Original Assignee
FH Faulding and Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by FH Faulding and Co Ltd filed Critical FH Faulding and Co Ltd
Publication of AU2087897A publication Critical patent/AU2087897A/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
AU20878/97A 1996-03-12 1997-03-12 Pharmaceutical compositions Abandoned AU2087897A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPN8625 1996-03-12
AUPN8625A AUPN862596A0 (en) 1996-03-12 1996-03-12 Pharmaceutical compositions
PCT/AU1997/000154 WO1997033621A1 (en) 1996-03-12 1997-03-12 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
AU2087897A true AU2087897A (en) 1997-10-01

Family

ID=3792937

Family Applications (2)

Application Number Title Priority Date Filing Date
AUPN8625A Abandoned AUPN862596A0 (en) 1996-03-12 1996-03-12 Pharmaceutical compositions
AU20878/97A Abandoned AU2087897A (en) 1996-03-12 1997-03-12 Pharmaceutical compositions

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AUPN8625A Abandoned AUPN862596A0 (en) 1996-03-12 1996-03-12 Pharmaceutical compositions

Country Status (2)

Country Link
AU (2) AUPN862596A0 (en)
WO (1) WO1997033621A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040141923A1 (en) * 1997-10-01 2004-07-22 Dugger Harry A. Buccal, polar and non-polar spray containing alprazolam
US20040136914A1 (en) 1997-10-01 2004-07-15 Dugger Harry A. Buccal, polar and non-polar spray containing ondansetron
EP0943341A1 (en) * 1998-02-18 1999-09-22 Oscar Gold Procedure to prepare granulated compositions that contain erythromycin macrolides and procedure to prepare pharmaceutical compositions that contain said macrolides
EP3129024A4 (en) * 2014-04-08 2017-11-22 Sansa Corporation (Barbados) Inc. Nicotine formulations and methods of making the same
US9585835B1 (en) * 2015-09-16 2017-03-07 Sansa Corporation (Barbados) Inc. Inhalable nicotine formulations and methods of making and using the same

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6029682B2 (en) * 1980-07-11 1985-07-12 山之内製薬株式会社 Bitter-free pharmaceutical composition and method for producing the same
GB8730011D0 (en) * 1987-12-23 1988-02-03 Smithkline Dauelsberg Pharmaceutical compositions
NZ234143A (en) * 1989-06-28 1991-10-25 Mcneil Ppc Inc Aqueous pharmaceutical suspension formulation for administering substantially insoluble pharmaceutical agents
EP0764014A1 (en) * 1994-06-10 1997-03-26 The Procter & Gamble Company Mouthrinse compositions
US5616621A (en) * 1995-01-30 1997-04-01 American Home Products Corporation Taste masking liquids
US5563177A (en) * 1995-01-30 1996-10-08 American Home Products Corporation Taste masking guaifenesin containing liquids

Also Published As

Publication number Publication date
WO1997033621A1 (en) 1997-09-18
AUPN862596A0 (en) 1996-04-04

Similar Documents

Publication Publication Date Title
AU4762797A (en) Pharmaceutical compositions
AU2967597A (en) Pharmaceutical compositions
AU6216296A (en) Pharmaceutical compositions
AU3049397A (en) Cyclosporin-containing pharmaceutical composition
AU6740298A (en) Pharmaceutical composition
AU5136998A (en) Medicinal composition
AU8107998A (en) Pharmaceutical compositions
AU3777897A (en) Pharmaceutical compositions
AU5317598A (en) Novel pharmaceutical compositions
AU5157898A (en) Hnf3delta compositions
GB9610359D0 (en) Pharmaceutical compositions
AU5274096A (en) Pharmaceutical compositions
AU2531295A (en) Pharmaceutical composition
AU9343098A (en) Pharmaceutical composition
AU5326298A (en) Pharmaceutical compositions containing N-sulphonylindoline derivatives
GB9622681D0 (en) Pharmaceutical compositions
AU3460897A (en) Medicinal compositions
GB9613457D0 (en) Pharmaceutical compositions
GB9606429D0 (en) Pharmaceutical compositions
AU4326197A (en) Pharmaceutical compositions
AU4457597A (en) Pharmaceutical compositions
AUPN862596A0 (en) Pharmaceutical compositions
AU1544195A (en) Pharmaceutical compositions
AU1427895A (en) Pharmaceutical compositions
GB9610136D0 (en) Pharmaceutical compositions